Skip to main content
Clinical Trials/NCT04726267
NCT04726267UnknownNot Applicable

Incidence of Complete Posterior Vitreous Detachment After Trabeculectomy.

Khon Kaen University1 site in 1 country46 target enrollmentStarted: July 1, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
46
Locations
1
Primary Endpoint
Incidence of PVD

Study Overview

Brief Summary

Intraocular surgery could induce vitreous degeneration and posterior vitreous detachment (PVD). Vitreomacular interface (VMI) abnormalities usually are caused by abnormal PVD, vitreoschisis and partial-thickness PVD. Furthermore, the PVD could induce the peripheral break. The incidence of peripheral break and epimacular membrane (EMM) after pneumatic retinopexy were 11.7% and 4-11%, respectively. Although multiple intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections induced PVD of 5.6%, but peripheral break was reported as only 0.67%.

The most common intraocular surgery is cataract surgery. From the literature review, many methods were used to detect the PVD after phacoemulsification. The former studies used indirect ophthalmoscopy and ocular ultrasound for diagnosis of PVD. The later studies used the optical coherence tomography (OCT) for PVD detection. The OCT device had higher effectiveness in evaluation of the posterior segment, then it can detect post-phacoemulsification PVD more and early than previous studies. Ivastinovic et al demonstrated 59.2% of patients had PVD at 1 month after phacoemulsification, and increased up to 71.4% at 3 months. The incidence of rhegmatogenous retinal detachment (RRD) after phacoemulsification is gradually increased with time. The accumulative risk of RRD was increased from 0.27% at 1 year to 1.27% at 20 years after phacoemulsification.

Detailed Description

Trabeculectomy is one of the intraocular surgery. Although the volume of intraocular fluid use during the trabeculectomy was much less than used during phacoemulsification, trabeculectomy also could induce the PVD and it's sequelae such as VMI abnormalities. Because the baseline visual acuity of glaucoma patients who were indicated for trabeculectomy usually quite poor, so the sequelae of PVD can cause more visual loss. The incidence of PVD after trabeculectomy has never been published before and nowadays no standard guideline for retinal examination or screening after surgery. Furthermore, Tsukahara et al introduced wide-field OCT-based PVD classification. The new OCT device with higher technology will be useful in PVD detection.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Primary open angle glaucoma or primary angle closure glaucoma
  • •Age 18-65 years
  • •Could be taken the wide-field OCT images
  • •Written informed consent

Exclusion Criteria

  • •History of intraocular inflammation or infection
  • •History of ocular trauma or head trauma
  • •History of intraocular surgery such as intravitreal drug injection and cataract surgery
  • •History of vitreoretinal diseases such as diabetic retinopathy, retinal vascular occlusion and age-related macular degeneration
  • •History of laser treatment including laser capsulotomy and retinal photocoagulation
  • •High myopia; spherical equivalence >4 diopters
  • •Complete PVD was detected before the enrollment

Arms & Interventions

Glaucoma patients who was scheduled for trabeculectomy

Other

Wide-field OCT was performed 1-2 weeks before the trabeculectomy. The OCT was done postoperatively at 1 month, 3 months, 6 months and 12 months after surgery.

Intervention: Wide-field optical coherence tomography (Device)

Outcomes

Primary Outcomes

Incidence of PVD

Time Frame: 12 months

complete PVD

Secondary Outcomes

  • The incidence of VMI abnormalities(12 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Suthasinee Sinawat

KKU Eye Center, Department of Ophthalmology

Khon Kaen University

Study Sites (1)

Loading locations...

Similar Trials